【丹麦讯】诺和诺德基金会，这个享誉全球的医药健康领域基金会，近日宣布了一项重大合作计划。该基金会与全球领先的图形处理器制造商英伟达携手，拟在丹麦构建一座名为“Gefion”的人工智能超级计算机，以加速新药和疗法的创新研发。这一消息在当地时间3月18日正式对外公布，引起了科技和医疗界的广泛关注。
Gefion超级计算机将搭载英伟达先进的AI技术，旨在通过强大的计算能力，为药物研发提供前所未有的精准预测和模拟。这台超级计算机不仅将服务于诺和诺德基金会自身的研发工作，还将向丹麦的公共和私营部门开放，为全国的研究人员提供宝贵的资源和工具，共同探索治疗各种疾病的新路径。
诺和诺德基金会的这一举措，展示了其对AI技术在医药健康领域应用的坚定信心和前瞻视野。通过与英伟达的强强联合，他们旨在打破传统药物研发的壁垒，提高新药发现的效率，为全球公共卫生事业带来革命性的改变。这一项目不仅是丹麦科技发展的一个里程碑，也是全球医疗创新领域的一次重大突破。
据《科创板日报》报道，这一合作项目将极大地推动丹麦乃至全球的科研进程，为未来的医疗健康解决方案提供强大的技术支持。诺和诺德基金会与英伟达的联手，无疑将为新药研发开启一个全新的智能时代。
英语如下：
**News Title:** “Novo Nordisk and NVIDIA Join Forces: Building an AI Supercomputer in Denmark to Accelerate Drug Discovery”
**Keywords:** AI Supercomputer, Novo Nordisk, Drug Discovery
**News Content:**
**COPENHAGEN** – The Novo Nordisk Foundation, a globally renowned healthcare philanthropy, recently announced a major collaboration. The foundation is teaming up with NVIDIA, the world’s leading graphics processing unit manufacturer, to construct an artificial intelligence (AI) supercomputer named “Gefion” in Denmark. This initiative aims to hasten the development of new drugs and therapies. The announcement was made on March 18, drawing significant attention from the tech and medical communities.
Equipped with NVIDIA’s cutting-edge AI technology, the Gefion supercomputer is designed to provide unprecedentedly precise predictions and simulations for drug development through its immense computational power. Not only will it support the foundation’s research efforts, but it will also be accessible to Denmark’s public and private sectors, furnishing researchers nationwide with valuable resources and tools to explore novel approaches to treating various diseases.
This move by the Novo Nordisk Foundation underscores its steadfast belief in the potential of AI in the healthcare sector and its forward-looking vision. By partnering with NVIDIA, they aim to break down barriers in traditional drug development, enhancing the efficiency of drug discovery and bringing about a transformative change in global public health. The project marks a milestone in Danish technological advancement and constitutes a significant breakthrough in global medical innovation.
As reported by the *Kechuang Board Daily*, this collaboration is set to significantly propel research progress in Denmark and globally, providing robust technological support for future healthcare solutions. The union of the Novo Nordisk Foundation and NVIDIA is poised to usher in a new era of intelligence in drug discovery.
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 2